267 related articles for article (PubMed ID: 26136189)
1. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.
Chen JA; Splenser A; Guillory B; Luo J; Mendiratta M; Belinova B; Halder T; Zhang G; Li YP; Garcia JM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):132-43. PubMed ID: 26136189
[TBL] [Abstract][Full Text] [Related]
2. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
Kerr HL; Krumm K; Lee II; Anderson B; Christiani A; Strait L; Breckheimer BA; Irwin B; Jiang AS; Rybachok A; Chen A; Caeiro L; Dacek E; Hall DB; Kostyla CH; Hales LM; Soliman TM; Garcia JM
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1337-1348. PubMed ID: 36942661
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass.
Liu H; Zang P; Lee II; Anderson B; Christiani A; Strait-Bodey L; Breckheimer BA; Storie M; Tewnion A; Krumm K; Li T; Irwin B; Garcia JM
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1280-1295. PubMed ID: 34264027
[TBL] [Abstract][Full Text] [Related]
4. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
5. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.
Brown JL; Lee DE; Rosa-Caldwell ME; Brown LA; Perry RA; Haynie WS; Huseman K; Sataranatarajan K; Van Remmen H; Washington TA; Wiggs MP; Greene NP
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):987-1002. PubMed ID: 30328290
[TBL] [Abstract][Full Text] [Related]
6. Acylated and unacylated ghrelin inhibit atrophy in myotubes co-cultured with colon carcinoma cells.
Zeng X; Chen S; Yang Y; Ke Z
Oncotarget; 2017 Sep; 8(42):72872-72885. PubMed ID: 29069832
[TBL] [Abstract][Full Text] [Related]
7. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy.
Chen JM; Yang TT; Cheng TS; Hsiao TF; Chang PM; Leu JY; Wang FS; Hsu SL; Huang CF; Lai JM
J Ethnopharmacol; 2019 Apr; 233():47-55. PubMed ID: 30590199
[TBL] [Abstract][Full Text] [Related]
8. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation
Liu H; Luo J; Guillory B; Chen JA; Zang P; Yoeli JK; Hernandez Y; Lee II; Anderson B; Storie M; Tewnion A; Garcia JM
Oncotarget; 2020 Sep; 11(35):3286-3302. PubMed ID: 32934774
[TBL] [Abstract][Full Text] [Related]
10. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
11. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin: from discovery to cancer cachexia therapy.
Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
[TBL] [Abstract][Full Text] [Related]
13. Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway.
Zhang H; Chi M; Chen L; Sun X; Wan L; Yang Q; Guo C
Front Pharmacol; 2020; 11():598166. PubMed ID: 33390985
[TBL] [Abstract][Full Text] [Related]
14. Control of food intake and muscle wasting in cachexia.
Amitani M; Asakawa A; Amitani H; Inui A
Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
17. GH-Releasing Hormone Promotes Survival and Prevents TNF-α-Induced Apoptosis and Atrophy in C2C12 Myotubes.
Gallo D; Gesmundo I; Trovato L; Pera G; Gargantini E; Minetto MA; Ghigo E; Granata R
Endocrinology; 2015 Sep; 156(9):3239-52. PubMed ID: 26110916
[TBL] [Abstract][Full Text] [Related]
18. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.
Conte E; Bresciani E; Rizzi L; Cappellari O; De Luca A; Torsello A; Liantonio A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069876
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Morales MG; Olguín H; Di Capua G; Brandan E; Simon F; Cabello-Verrugio C
Clin Sci (Lond); 2015 Sep; 129(6):461-76. PubMed ID: 25989282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
